Case File
efta-01449662DOJ Data Set 10OtherEFTA01449662
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01449662
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
SOUTHERN FINANCIAL, 1.I.0 ACCT.
For the Period 8/1/13 to S/31/13
Note
Unrealized Gain Loss is shown as "N. A" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan learn (or additional
information.
Equity Detail
Price
Quantity
Value
Adjusted Cost
Original Cost
Unrealized
GalnA.oss
Est. Annual Inc.
Accruec
—liW7
Yield
US Large Cap Equity
ARIAD PHARMACEUTICALS INC
04033A-10-0 ARIA
18.60
16.535 000
307,551.00
290,997.40
16,553.60
BIOGEN IDEC INC
09062X-104 BNB
213.02
2,099.000
448,276.90
250,454.95
199,821.95
FACEBOOK 1NC-A
30303M-10-2 FB
41.29
17,500.000
722,645.00
665,000.00
67,645.00
GENERAL ELECTRIC CO
369604-10-3 GE
23.14
23,000.000
532,220.00
496,109.06
36,110.92
17,480.00
3.28%
JPM VALUE ADVANTAGE FD -INSIL
FUND 1400
4812A2-58-7 JVAI X
24.96
78,709.170
1.964.580.88
2,000,000.00
(35,419.12)
19,992.12
1.02%
Total US Large Cap Equity
US Small/Mid Cap Equity
DEUTSCHE 8K AG LDN BRH
DBL LONG ETN38
25154H-55-8 DAG
8.90
50,000.000
53,973,273.78
445800 00
53,702,561.43
352.529.00
$270,712.36
92,471.00
937,472.12
0.94%
J.P Morgan
Accounnage
5 of 48
Consolidated Statement Page 8
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0 105116
CONFIDENTIAL
SDNY_GM_00251300
EFTA01449662
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.